NCT04739280View on ClinicalTrials.gov

Women's Assessed Cardiovascular Evaluation With MCG

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

July 21, 2022

Study Completion Date

July 21, 2022

Conditions
IschemiaCardiac DiseaseRisk Factor, Cardiovascular
Interventions
DEVICE

CardioFlux Magnetocardiography

Magnetocardiography

Trial Locations (1)

45040

Genetesis Facility, Mason

Sponsors

Lead Sponsor

Genetesis Inc.
All Listed Sponsors
lead

Genetesis Inc.

INDUSTRY

NCT04739280 - Women's Assessed Cardiovascular Evaluation With MCG | Biotech Hunter | Biotech Hunter